Compare stocks

Dottikon ES Holding AG is a Swiss-based company specializing in the development and production of performance chemicals, primarily focusing on the pharmaceutical industry. The company is known for its hazardous reactions expertise, which supports its clients in drug development and production processes. Dottikon ES offers services and products including exclusive synthesis, process development, and related toll manufacturing. Headquartered in Dottikon, Switzerland, the company leverages its strategic positioning by focusing on safety, quality, and flexibility to meet specific customer needs in complex chemical reactions.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.